Getein Biotech, Inc (SHA:603387)

China · Delayed Price · Currency is CNY

8.69

-0.07 (-0.80%)

At close: Feb 13, 2026

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Point of Care Testing Conventional Series	620.59M
Point of Care Testing Conventional Series Growth	-16.10%
Chemiluminescence Series	265.18M
Chemiluminescence Series Growth	31.14%
Three Inspections, Copperative Construction and Others	167.04M
Three Inspections, Copperative Construction and Others Growth	-38.84%
Biochemistry, Hematology and Others	106.70M
Biochemistry, Hematology and Others Growth	-12.77%
Point of Care Testing COVID-19 Series	5.28M
Point of Care Testing COVID-19 Series Growth	-83.40%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
China	1.02B
China Growth	-16.91%
Overseas	142.44M
Overseas Growth	2.63%